1. Case Report Myocardial ischemia in a patient with acute lymphoblastic leukemia during l-asparaginase therapy.
- Author
-
Saviola, Alessia, Luppi, Mario, Potenza, Leonardo, Morselli, Monica, Bresciani, Paola, Ferrari, Angela, Riva, Giovanni, and Torelli, Giuseppe
- Subjects
- *
CORONARY disease , *LYMPHOBLASTIC leukemia , *ASPARAGINASE , *THERAPEUTIC complications , *FIBRINOGEN , *VINCRISTINE , *DRUG therapy - Abstract
Saviola A, Luppi M, Potenza L, Morselli M, Bresciani P, Ferrari A, Riva G, Torelli G. Myocardial ischemia in a patient with acute lymphoblastic leukemia during l-asparaginase therapy. Eur J Haematol 2004: 72: 71–72. © Blackwell Munksgaard 2004. Haemostatic abnormalities may occur in 1–2% of patients treated with l-asparaginase. Here, we present the second case of a myocardial infarction, developing in a patient with acute lymphoblastic leukemia (ALL), in the course of l-asparaginase treatment. In our patient and in the only one reported case from the literature, a recent exposure to vincristine and daunorubicin was also reported, but induction chemotherapy program was completed as scheduled, with the only withdrawal of l-asparaginase. Myocardial infarction should be included in the list of thrombotic complications possibly associated with l-asparaginase treatment, or with a combination of l-asparaginase and vinca alkaloids/anthracycline. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF